World supplier of antibodies, antigens and kits since 2007
Other Products
PROTAK™ Lenalidomide (CC-5013)
$170/ 50mg
Specification
QuantityTotal: $170
Ship worldwide. Contact order@enogene.com for ordering and bulk pricing or contact your local distributor.
Product Information
CAS No.191732-72-6
Name3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
Purity>98.00%
FormulaC13H13N3O3
M.W.259.3
Solubility≥100.8 mg/mL in DMSO, <2.29 mg/mL in EtOH, <2.53 mg/mL in H2O
Storage/StabilityStore at -20°C
BackgroundLenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. It has been extensively studied for the treatment of multiple myeloma and myelodysplastic syndrome as well as lymphoproliferative disorders including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma. According to recent studies, Lnalidomide promotes and restores immune system function in CLL patients by inducing an overexpression of costimulatory molecules in leukemic lymphocytes to restore the humoral immunity and immunoglobulins production as well as improving the ability of T cells and leukemic cells to form synapses with T lymphocytes..
Price170$
E31P14976-1, E31P14976-2 PROTAK™ Lenalidomide (CC-5013) 50mg,100mg 191732-72-6 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
Categories by research area
Categories by product type
- Antibodies
- Primary Antibodies
- Tag antibodies
- Internal control antibodies
- Pathological (Immunohistochemistry, IHC) antibodies
- Cell Signal Transduction Research Antibodies
- Secondary Antibody
- Antibody Sampler Kits
- ELISA Kits
- Recombinant Proteins
- Fluorescence Reagents
- Signal Inhibitors and Activators
- Transfection Reagent
- Cell biology kits
- Overexpression Cell Lines
- Cell Lysates
- Purification Resins
- 2019-nCoV & Monkeypox